Menu
Back to Journals » Clinical Ophthalmology » Volume 13
Corrigendum
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,672 | Dovepress* | 5,464+ | 1,473 | 6,937 | |
| PubMed Central* | 208 | 80 | 288 | ||
| Totals | 5,672 | 1,553 | 7,225 | ||
| *Since 24 January 2019 | |||||
View citations on PubMed Central and Google Scholar